Table 3.
Variable | N | NPLN | LNR | LODDS | ENE | |||||
---|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
Age(years) | ||||||||||
<65 | 1 | 1 | 1 | 1 | 1 | |||||
≥65 | 1.801(1.186–2.734) | 0.006 | 1.817(1.197–2.760) | 0.005 | 1.742(1.150–2.641) | 0.009 | 1.758(1.159–2.666) | 0.008 | 1.687(1.114–2.555) | 0.014 |
Nerve invasion | ||||||||||
NO | 1 | 1 | 1 | 1 | 1 | |||||
YES | 1.958(1.261–3.309) | 0.003 | 1.914(1.255–3.027) | 0.003 | 1.988(1.279–3.092) | 0.002 | 1.985(1.276–3.087) | 0.002 | 1.907(1.216–2.990) | 0.005 |
Vessel invasion | ||||||||||
NO | 1 | 1 | 1 | 1 | 1 | |||||
YES | 1.120(0.716–1.751) | 0.62 | 1.118(0.714–1.749) | 0.627 | 1.503(0.665–1.668) | 0.824 | 1.057(0.667–1.676) | 0.814 | 1.087(0.683–1.730) | 0.752 |
N stage | ||||||||||
N1 | 1 | |||||||||
N2 | 1.950(1.279–2.837) | 0.002 | ||||||||
NPLN | ||||||||||
NPLN1 | 1 | |||||||||
NPLN2 | 1.934(1.297–2.883) | 0.001 | ||||||||
LNR | ||||||||||
LNR1 | 1 | |||||||||
LNR2 | 1.714(1.123–2.615) | 0.013 | ||||||||
LODDS | ||||||||||
LODDS1 | 1 | |||||||||
LODDS2 | 1.654(1.082–2.530) | 0.02 | ||||||||
ENE | ||||||||||
ENE1 | 1 | |||||||||
ENE2 | 1.429(0.938–2.177) | 0.097 |
Abbreviations: LNM, Lymph node metastasis; LNR, lymph node ratio; NPLN, number of positive lymph nodes; NDLN, number of dissected lymph nodes; LODDS, log ODDS; ENE, Extranodal extension.